furosemide has been researched along with Weight Gain in 13 studies
Furosemide: A benzoic-sulfonamide-furan. It is a diuretic with fast onset and short duration that is used for EDEMA and chronic RENAL INSUFFICIENCY.
furosemide : A chlorobenzoic acid that is 4-chlorobenzoic acid substituted by a (furan-2-ylmethyl)amino and a sulfamoyl group at position 2 and 5 respectively. It is a diuretic used in the treatment of congestive heart failure.
Weight Gain: Increase in BODY WEIGHT over existing weight.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The open, long-term antihypertensive, hemodynamic and metabolic effects of betaxolol in combination with furosemide and minoxidil were investigated on 30 male patients with moderate to severe essential hypertension." | 9.07 | Cardiac changes from beta-blocker, diuretic and minoxidil combination in hypertension. ( Berlin, L; Chrysant, C; Chrysant, SG; Sadeghi, M, 1991) |
| "Furosemide (F)-induced nephrocalcinosis (NC) has been traditionally described in low birth weight premature infants." | 7.70 | Effect of age on furosemide-induced nephrocalcinosis in the rat. ( Alon, MM; Alon, US; Nichols, MA; Osorio, AV, 1998) |
| "Furosemide treatment in the human neonate is associated with sodium depletion, growth retardation, hypercalciuria and nephrocalcinosis." | 7.69 | Salt supplementation, growth, and nephrocalcinosis in the furosemide-treated weanling rat. ( Alon, US; Gratny, LL; Hall, RT; Ringer, K, 1997) |
| "The open, long-term antihypertensive, hemodynamic and metabolic effects of betaxolol in combination with furosemide and minoxidil were investigated on 30 male patients with moderate to severe essential hypertension." | 5.07 | Cardiac changes from beta-blocker, diuretic and minoxidil combination in hypertension. ( Berlin, L; Chrysant, C; Chrysant, SG; Sadeghi, M, 1991) |
| "Furosemide (F)-induced nephrocalcinosis (NC) has been traditionally described in low birth weight premature infants." | 3.70 | Effect of age on furosemide-induced nephrocalcinosis in the rat. ( Alon, MM; Alon, US; Nichols, MA; Osorio, AV, 1998) |
| "We investigated the pattern of functional renal maturation and electrolyte handling on postnatal day 1, (PD1), day 5 (PD5), and day 12 (PD12) in rat neonates, after mothers were given furosemide during pregnancy." | 3.69 | Functional renal maturation in rat neonates after prenatal exposure to furosemide. ( Boudzoumou, P; Mallie, JP, 1996) |
| "Furosemide treatment in the human neonate is associated with sodium depletion, growth retardation, hypercalciuria and nephrocalcinosis." | 3.69 | Salt supplementation, growth, and nephrocalcinosis in the furosemide-treated weanling rat. ( Alon, US; Gratny, LL; Hall, RT; Ringer, K, 1997) |
| "Furosemide 20 mg/kg was administered intravenously to rats pretreated with various CYP inducers--3-methylcholanthrene, orphenadrine citrate and isoniazid, inducers of CYP1A1/2, 2B1/2 and 2E1, respectively, in rats--and inhibitors--SKF-525A (a non-specific inhibitor of CYP isozymes), sulfaphenazole, cimetidine, quinine hydrochloride and troleandomycin, inhibitors of CYP2C6, 2C11, 2D and 3A1/2, respectively, in rats." | 1.35 | Effects of cytochrome P450 inducers and inhibitors on the pharmacokinetics of intravenous furosemide in rats: involvement of CYP2C11, 2E1, 3A1 and 3A2 in furosemide metabolism. ( Choi, YH; Lee, JH; Lee, MG; Lee, U; Yang, KH, 2009) |
| "Furosemide (Furo) is a potent natriuretic drug that is often used experimentally to investigate the brain mechanisms underlying salt appetite." | 1.32 | Furosemide-induced food avoidance: evidence for a conditioned response. ( Bradley, C; Caloiero, V; Liang, NC; Lundy, RF; Norgren, R, 2004) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (30.77) | 18.2507 |
| 2000's | 5 (38.46) | 29.6817 |
| 2010's | 3 (23.08) | 24.3611 |
| 2020's | 1 (7.69) | 2.80 |
| Authors | Studies |
|---|---|
| Nayyar, K | 1 |
| Imbriano, LJ | 1 |
| Miyawaki, N | 1 |
| Maesaka, JK | 1 |
| Grzeskowiak, MZ | 1 |
| Ahmed, N | 1 |
| Yang, KH | 1 |
| Choi, YH | 1 |
| Lee, U | 1 |
| Lee, JH | 1 |
| Lee, MG | 1 |
| Tuchman, S | 1 |
| Asico, LD | 1 |
| Escano, C | 1 |
| Bobb, DA | 1 |
| Ray, PE | 1 |
| Mank, A | 1 |
| Semin-Goossens, A | 1 |
| Lelie, Jv | 1 |
| Bakker, P | 1 |
| Vos, R | 1 |
| Lundy, RF | 1 |
| Caloiero, V | 1 |
| Bradley, C | 1 |
| Liang, NC | 1 |
| Norgren, R | 1 |
| Ahn, D | 1 |
| Ge, Y | 1 |
| Stricklett, PK | 1 |
| Gill, P | 1 |
| Taylor, D | 1 |
| Hughes, AK | 1 |
| Yanagisawa, M | 1 |
| Miller, L | 1 |
| Nelson, RD | 1 |
| Kohan, DE | 1 |
| Mallie, JP | 1 |
| Boudzoumou, P | 1 |
| Gratny, LL | 1 |
| Ringer, K | 1 |
| Hall, RT | 1 |
| Alon, US | 2 |
| Osorio, AV | 1 |
| Alon, MM | 1 |
| Nichols, MA | 1 |
| Jonassen, TE | 1 |
| Sørensen, AM | 1 |
| Petersen, JS | 1 |
| Andreasen, F | 1 |
| Christensen, S | 1 |
| Chrysant, SG | 1 |
| Chrysant, C | 1 |
| Sadeghi, M | 1 |
| Berlin, L | 1 |
| Salem, AZ | 1 |
| Kholif, AE | 1 |
| Olivares, M | 1 |
| Elghandour, MM | 1 |
| Mellado, M | 1 |
| Arece, J | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Reliability and Utility of Fluid Balance Charting in Neonates Admitted to the Pediatric Ward.[NCT00962754] | Phase 4 | 170 participants (Actual) | Interventional | 2009-06-30 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
notifications of complications (NCT00962754)
Timeframe: duration of admission
| Intervention | participants (Number) |
|---|---|
| Physician Insight Fluid Balance | 2 |
| Physician no Insight Fluid Balance Chart | 5 |
Duration of hospital stay in days or duration of admission at the pediatric ward in days (NCT00962754)
Timeframe: 1-8 months
| Intervention | number of days (Median) |
|---|---|
| Intervention Group (no Insight in Fluid Balance) | 9 |
| Control Group (Insight in Fluid Balance) | 8 |
prescription of diuretic therapy (NCT00962754)
Timeframe: during days of admission
| Intervention | participants (Number) |
|---|---|
| Intervention Group (no Insight in Fluid Balance) | 0 |
| Control Group (Insight in Fluid Balance) | 0 |
1 review available for furosemide and Weight Gain
| Article | Year |
|---|---|
Pathophysiologic approach to understanding and successfully treating idiopathic edema: Unappreciated importance of nocturia.
Topics: Edema; Female; Furosemide; Humans; Hydrochlorothiazide; Nocturia; Quality of Life; Sodium; Weight Ga | 2022 |
2 trials available for furosemide and Weight Gain
| Article | Year |
|---|---|
Cardiac changes from beta-blocker, diuretic and minoxidil combination in hypertension.
Topics: Betaxolol; Cardiomegaly; Drug Therapy, Combination; Edema; Furosemide; Humans; Hypertension; Male; M | 1991 |
Influence of S. babylonica extract on feed intake, growth performance and diet in vitro gas production profile in young lambs.
Topics: Animal Feed; Animal Nutritional Physiological Phenomena; Animals; Diet; Dietary Supplements; Eating; | 2014 |
10 other studies available for furosemide and Weight Gain
| Article | Year |
|---|---|
Case of giant left atrium from congestive heart failure.
Topics: Aged; Atrial Fibrillation; Cardiac Output, Low; Cardiomegaly; Echocardiography; Female; Furosemide; | 2018 |
Effects of cytochrome P450 inducers and inhibitors on the pharmacokinetics of intravenous furosemide in rats: involvement of CYP2C11, 2E1, 3A1 and 3A2 in furosemide metabolism.
Topics: Animals; Area Under Curve; Aryl Hydrocarbon Hydroxylases; Cimetidine; Cytochrome P-450 Enzyme System | 2009 |
Development of an animal model of nephrocalcinosis via selective dietary sodium and chloride depletion.
Topics: Animals; Blood Pressure; Calcium; Chlorides; Disease Models, Animal; Furosemide; Kidney; Male; Nephr | 2013 |
Monitoring hyperhydration during high-dose chemotherapy: body weight or fluid balance?
Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Body Water; Body Weight; Cohort Studies; Confounding | 2003 |
Furosemide-induced food avoidance: evidence for a conditioned response.
Topics: Animals; Appetite; Avoidance Learning; Conditioning, Operant; Cues; Diuretics; Dose-Response Relatio | 2004 |
Collecting duct-specific knockout of endothelin-1 causes hypertension and sodium retention.
Topics: Aldosterone; Amiloride; Animals; Blood Pressure; Diuretics; Endothelin-1; Furosemide; Heterozygote; | 2004 |
Functional renal maturation in rat neonates after prenatal exposure to furosemide.
Topics: Animals; Animals, Newborn; Diuretics; Electrolytes; Female; Furosemide; Kidney; Male; Pregnancy; Pre | 1996 |
Salt supplementation, growth, and nephrocalcinosis in the furosemide-treated weanling rat.
Topics: Animals; Calcium; Electrolytes; Furosemide; Homeostasis; Nephrocalcinosis; Rats; Rats, Sprague-Dawle | 1997 |
Effect of age on furosemide-induced nephrocalcinosis in the rat.
Topics: Aging; Animals; Calcium; Diuresis; Drinking; Eating; Furosemide; Male; Nephrocalcinosis; Rats; Rats, | 1998 |
Increased natriuretic efficiency of furosemide in rats with carbon tetrachloride-induced cirrhosis.
Topics: Animals; Carbon Tetrachloride; Diuresis; Diuretics; Female; Furosemide; Hemodynamics; Kidney Tubules | 2000 |